Deregulation of Hh/Gli signaling is implicated as an initiating or maintaining factor in the progression of various cancers, including basal cell carcinomas, medulloblastomas, leukemia, lung, gastrointestinal, lung, ovarian, breast and prostate cancers [19], [21]. Here, GLI1 is linked to cancer.